Rising UK unemployment sets scene for March interest rate cut

UK unemployment rose to 5.2% in the three months to December 2025 as the impact of Labour’s economic policies hit the jobs market.

The last quarter of 2025 saw UK economic activity flatline as businesses reacted to the uncertainty around the budget and associated tax increases. We now know this led to slower wage growth and higher unemployment.

“UK unemployment has climbed to 5.2%, its highest level in nearly five years, while private-sector wage growth slowed to 3.4% which is the weakest pace since 2020,” said Lale Akoner, global market analyst at eToro.

“It is clear the UK labour market is cooling and inflation pressures from wages are fading.”

Wage inflation is one of the key indicators cited by the Bank of England as a reason to be cautious around interest rate cuts. Nowthat wage growth is slowing alongside rising unemployment, the BoE will have no excuse not to cut interest rates at the upcoming meeting in March.

“And crucially, from the perspective of the Bank of England and the outlook for inflation, this weakness is continuing to pull down on wage growth,” explained Luke Bartholomew, Deputy Chief Economist, at Abderdeen.

“Private sector pay growth in particular has essentially returned to an inflation-target consistent rate, meaning that as and when inflation falls to 2% later this year it is likely to stay there rather than start increasing again. Of course, the inflation data tomorrow could throw a wrench in the works, but for now it seems there is a clear case for a further rate cut at the Bank’s next meeting in March, and we continue to expect rates to fall to 3% later this year.” 

Interest rate markets are now pricing two interest rate cuts in 2026.

AIM movers: SkinBioTherapeutics discovers misrepresentation and US contract for Pebble Beach Systems

1

Broadcast technology supplier Pebble Beach Systems (LON: PEB) has won a five-year contract in the US worth £1.3m. There is scope for upside with the US streaming client. This boosts recurring revenues. Cavendish had previously upgraded its 2026 pre-tax profit forecast to £2.7m, and this contract helps to underpin the current estimate. The share price gained 12.15 to 18.5p.

Cognitive assessment products company Cambridge Cognition (LON: COG) has secured a non-exclusive partnership with Ivory that will enable the company to enter the market in India. Forecasts have not been changed due to the uncertainty about the rate of progress in India. This follows a pilot agreement in Europe. Cambridge Cognition could reach breakeven this year. The share price increased 10.1% to 43.5p.

Prospex Energy (LON: PXEN) has restarted the El Romeral power plant in Andalucia, following the repairing of a transformer failure, and electricity sales have commenced from a rental transformer. This is earlier than expected. It will run overnight when prices are higher. The replacement transformer will take six months to arrive. Tom Reynolds has started as chief executive. Hannam & Partners retains its risked NAV at 14.1p/share. The share price improved 8.47% to 3.2p.

Block Energy (LON: BLOE) says a report by Oilfield Production Consultants confirms technical viability of the carbon capture and storage (CCS) project in Georgia. A feasibility study to evaluate requirements and scalability will be undertaken. The share price rose 7.69% to 1.05p.

FALLERS

Skin treatments developer SkinBioTherapeutics (LON: SBTX) has slumped further following last week’s resignation of chief executive Stuart Ashman due to the misrepresentation of information. More details have been provided of the board investigation, and this will lead to the reversal of all accrued royalty income for 2024-25. That was £770,000, so it reduces 2024-25 revenues to £4.64m. This could be an isolated incident, but the investigation continues. This year’s figures will be below expectations, when a performance near to breakeven had been estimated. The underlying potential for the business is thought to be unchanged. There is still £2.92m in the bank, down from £4.78m at the end of June 2025. Given the expected underperformance, it appears more cash will be required this year. The share price dived 49.5% to 6.25p. OptiBiotix Health (LON: OPTI) still owns 5.63% of SkinBioTherapeutics and its share price dipped 7.14% to 5.85p.

Mathematical modelling and biostatistics services provider Physiomics (LON: PYC) increased interim total income from £354,000 to £528,000, including grants.  The operating loss rose from £249,000 to £327,000. The share price slipped 11.5% to 0.575p.

On Friday, Genedrive (LON: GDR) completed a £4m subscription and placing at 1p/share and an eight-for-55 open offer is planned that could raise up to £1.5m. David Nugent is converting his £500,000 loan into shares at the same price. The share price declined 8.33% to1.1p.

Infrastructure-as-a-Service automated trading products supplier Beeks Financial Cloud (LON: BKS) says interim trading is in line with expectations. Revenues are estimated to be £14.7m, down from £15.8m. Contracts won late in the period will contribute in the second half. That could contribute around £3.5m to second half revenues. Net cash is £3.3m. The share price fell 4.39% to 218p.

FTSE 100 higher with US closed for Presidents’ Day

The FTSE 100 was marginally higher on Monday as UK stocks ticked gently higher, with US markets closed for Presidents’ Day and a lack of catalysts to move the needle.

After touching highs around 10,490 in early trading on Monday, the FTSE 100 eased back to 10,470, up 0.2% on the day.

“A strong showing from financials helped to support the FTSE 100 on a quiet day for corporate news,” says Dan Coatsworth, head of markets at AJ Bell.

“NatWest, Barclays and Prudential took the top spots on the FTSE 100 risers’ list. The industrials and real estate sectors were also in demand, while housebuilders were out of fashion amid negative broker comment. Gold was down nearly 1% to trade just above $5,000 per ounce.”

After a torrid week for NatWest, shares showed signs of life as value seekers stepped in, sending the bank to the top of the leaderboard with a 4% gain. NatWest is still 11% lower over the past 10 trading days.

Although Monday was a relatively slow day for blue-chip newsflow, the lull won’t last for long with a raft of updates from large caps slated for the rest of the week.

“It’s another big week for UK investors, led by miners, with Rio Tinto expected to report a strong finish to the year after record production across iron ore, copper and lithium. Cash flow may look lighter thanks to heavy investment, but firmer commodity prices and a clearer path into 2026 should keep the focus on what comes next rather than what’s gone,” explained Matt Britzman, senior equity analyst, Hargreaves Lansdown.

“Anglo American’s results should look more mixed, with better iron ore offset by weaker copper and a sharply reduced dividend putting the outlook under the microscope. Shifting to the defence space, BAE Systems reports with strong momentum, a bulging order book and high hopes that rising global defence spending can keep growth ticking over into 2026.”

BAE Systems was higher on Monday, along with Babcock, as traders positioned for reports that the UK government was planning to boost defence spending earlier than previously thought.

Babcock added 3.7% and BAE Systems rose 2.8%.

Chemring Group: AGM Trading Update due this week, record Order Book

This coming Friday morning, 20th February, will see the £1.39bn-capitalised Chemring Group (LON:CHG) issue a Trading Update ahead of holding its AGM on that day. 
The group focuses upon niche, high-margin markets with global reach and high barriers to entry – including advanced sensors, electronic warfare, cyber and energetic materials.  
Those sectors benefit from resilient, long-term demand, underpinned by rising defence budgets, geopolitical tensions and the need to modernise and increase industrial capabil...

Pinewood Technologies shares sink as Apax calls off takeover

Pinewood Technologies shares sank on Monday after Apax Partners confirmed it does not intend to make an offer for the company, citing challenging market conditions.

Apax had reportedly been lining up a 500p-per-share offer for Pinewood. Pinewood shares sank 29% to 307p on Monday after Apax called off the takeover.

Without actually spelling this out in their statement, US private equity group Apax has probably seen the disruption to the wider software industry caused by AI and has gotten cold feet.

As a provider of software and intelligence to the automotive industry, Pinewood’s dashboard approach to data insights could face competition from AI tools that offer similar insights at a lower cost.

Dan Coatsworth, head of markets at AJ Bell, said: “Pinewood is a technology provider to car retailers and manufacturers and has gone big in AI-related services.

“Two years ago, that strategic development would have attracted hoards of investors wanting exposure to all things AI. In 2026, the reverse is true as investors panic about companies being disrupted by the big AI platform providers including Anthropic and OpenAI.”

Nonetheless, the Pinewood board said it remains confident in the group’s long-term prospects, citing its position as an embedded technology provider to automotive retailers and OEMs, with high recurring revenue.

Pinewood.AI highlighted recent strategic progress, including its February 2025 acquisition of Seez, which bolstered its AI and customer engagement capabilities, and full ownership of Pinewood North America.

Separately, a new contract with Lithia is expected to generate approximately $60 million in annual revenue by the end of 2028, strengthening the company’s position in the North American dealer software market.

The Pinewood board reiterated its medium-term FY28 guidance of underlying EBITDA of £58–62 million.

ITM Power gets go-ahead on 20MW project

ITM Power shares rose on Monday after the company confirmed receipt of a Notice to Proceed for a 20MW project following the customer’s Final Investment Decision.

Although the update didn’t specifically name a project, it could relate to the MorGen 20MW West Wales Hydrogen project in Milford Haven announced in August last year. ITM will deploy POSEIDON, its 20 MW modular electrolyser platform, at the project.

The NtP formally authorises ITM to begin full project work and sets the official contract start date. The contract will now be added to the company’s contracted order backlog.

ITM expects to provide further project details towards the end of the first quarter of 2026.

“We are proud that we have been entrusted to deliver yet another important industrial-scale project, and we are looking forward to providing more information on the project specifics in due course,” said Dennis Schulz.

Helium One Global shares jump on encouraging Tanzania testing data

Helium One Global is firing on all cylinders with positive news from its Tanzanian helium project, released today, following an encouraging update on its  Colorado-based Galactica project last week.

The company has completed Electrical Submersible Pump (ESP) testing at its ITW-1 well in the southern Rukwa Helium Project in Tanzania, delivering a significant increase in flow performance.

Helium One shares were 20% higher at the time of writing.

Over a 20-day testing period, the well produced the equivalent of more than 250,000 barrels of water, achieving flow rates of up to 16,400 barrels per day – a six-fold increase compared with natural flow rates recorded during the 2024 Extended Well Test.

Helium concentrations were sustained at 5.4% (air corrected), with a peak reading of 9.2% at the surface. Average gas-to-water ratio readings were 0.06 m³/m³, peaking at 0.1 m³/m³ during continuous flow. Downhole temperature and salinity data indicate fluid mixing from both Basement and Karoo Group aquifer sources.

Encouragingly, wellhead and downhole pressures re-pressurised quickly upon shut-in, suggesting robust reservoir support.

With testing now complete, Helium One said it will commence a strategic farmout process to identify and select a suitable industry partner for the project’s next phase of development.

“The successful completion of the ESP testing programme represents an important operational milestone for Helium One and further demonstrates the production potential of the southern Rukwa Helium Project,” said James Smith, Chairman, Helium One.

“The testing delivered consistent and reliable operational performance, with ESP flow rates exceeding expectations and sustained helium concentrations in line with anticipated ranges. Whilst the gas water ratio was towards the lower end of the expected outcome range, the results provide valuable technical insight and further support the Company’s understanding of the subsurface system.”

Director deals: One Health boss buys

Outsourced treatments and surgery provider One Health Group (LON: OHGR) boss Adam Binns has been buying shares following the latest trading statement. He acquired 2,229 shares at 224p each, followed by 1,113 shares at 224p each and then 1,115 shares at 224p each. That takes the chief executive’s stake to 14,457 shares.
Business
One Health provides NHS-funded outsourced treatments and surgery in orthopaedics, spine, gynaecology, urology and general surgery. It was formed two decades ago. NHS qualified provider status was obtained in 2012. The government wants to cut waiting lists and One Health...

AIM weekly movers: Aferian extends loan ahead of potential sale

4

Helium One Global (LON: HE1) says the installation of production facilities at the Pinyon Canyon plant at the 50% owned Galactica-Pegasus helium development in Tanzania is progressing. This will increase production capacity. The share price jumped 79.3% to 0.78p.

Trading in Celsius Resources (LON: CLA) shares recommenced trading on the ASX on 9 February. This followed a successful court case over the resignation of an auditor in 2011. The share price recovered 54.8% to 1.2p.

South east Asia gas explorer Sunda Energy (LON: SNDA) has entered an unsecured loan agreement with chief executive Dr Andy Butler of up to £1.5m. The initial draw down is £400,000. This will help to fund the transaction costs for the proposed acquisition od a portfolio of oil and gas assets. A revised farm in agreement for 60% owned Timor-Leste TL-SO 19 16 PSC is being discussed with partner TIMOR GAP. The share price increased 54.8% to 0.039p.

Gift packaging and stationery supplier IG Design (LON: IGR) is trading ahead of expectations. In the nine months to December 2025, margins of 4% are at the higher end of guidance. Full year pre-tax profit estimate has been raised from $7.1m to $9.9m. Cash could be more than $55m at the end of March 2026. A new chief executive is being recruited. The full year results will be published in June and there will be a return to reporting in pounds. The share price rebounded 36.4% to 64.4p.

FALLERS

Video streaming technology developer Aferian (LON: AFRN) has extended its $16.5m banking facilities to 20 March 2026. It could be further extended at a later date. The loan from major shareholder kestrel Partners is £1.59m and is repayable on 15 April 2026. The formal sale process continues, and this is leading to significant adviser costs. Some potential options for the trading businesses would not raise as much as the bank facility. The share price slumped 69.1% to 0.4254p.

Faron Pharmaceuticals (LON: FARN) is planning to raise €40m to enable acceleration of development of its lead asset bexmarilimab and to run the Phase II portion of the FDA agreed Phase II/III trial in frontline high risk myelodysplastic syndrome. Lead asset bexmarilimab is an investigational immunotherapy designed to overcome resistance to existing cancer treatments by harnessing the power of immune cells and igniting the immune system. Management expects value inflection points in 2026 and 2027. The share price declined 67.5% to 54.5p.

Phoenix Copper (LON: PXC) has suspended chief executive Marcus Edwards-Jones and finance director Richard Wilkins due to their recent conduct and past payments. An investigation is underway. The company has limited cash available, and it will last until the second quarter of 2026. The share price halved to 1p.

Skin treatments developer SkinBioTherapeutics (LON: SBTX) chief executive has resigned after having been suspended due to investigations into his conduct. Martin Hunt has become executive chairman. There is no further comment about what has happened. Mark Dixon has raised his shareholding to 20.45%. The share price slipped 38.9% to 12.375p.

Aquis weekly movers: Delta Gold Technologies university partnership

Quantum computing IP developer Delta Gold Technologies (LON: DGT) has secured a research sponsorship and technology licensing agreement with Penn State University. The sponsorship could cost $2.99m over three years. This will provide exclusive access to IP developed. Penn State will receive a running royalty of 1% of net sales of licensed products once net sales exceed $20m. The share price increased 35.8% to 36p.

Wishbone Gold (LON: WSBN) has expanded its interests in the area of Greatland Gold (GGP) owned Telfer gold mine in Western Australia. The company won a tender for 67km2 of mineral title on crown land, 25km north-west of Telfer. The share price rose 12.3% to 77.5p.

EPE Special Opportunities (LON: EO.P) had was cash of £14.1m at the end of January 2026. The NAV was 360p/share. The Luceco (LON: LUCE) share price recovered, and Whittard of Chelsea was refinanced. Recent acquisition LSA has been integrated into Rayware. A £3m share buyback has been launched. The share price gained 9.68% to 170p.

Oscillate (LON: SRVL) has agreed to acquire Kalahari Copper, which has interests in the Kaoko Basin in Namibia and the Kalahari copper belt in Botswana. The acquisition will be combined with a move to AIM. A further $80,000 has been received from Pulsar Helium Inc for the sale of hydrogen assets. One more payment of $80,000 is due. The share price improved 9.09% to 0.6p.

Sulnox Group (LON: SNOX) has secured a distribution agreement with Motor Plus Panama, which will stock Sulnox emission reduction products for maritime, industrial and transport clients. The share price is 4.35% higher at 60p.

Valereum (LON: VLRM) has signed a Memorandum of Understanding with RWO.io, which will integrate VLRM markets into its infrastructure. Longer-term, there are plans to develop a decentralised exchange and enable token assets to be used to secure loans.  The share price edged up 2.22% to 11.5p,

FALLERS

Falconedge (EDGE) generated income of 0.368524 Bitcoin, taking the total Bitcoin holding to 19.878377 Bitcoin. The share price fell 9.22% to 0.935p.